Mehdi Alexandre Manga is a biotech entrepreneur and strategic catalyst specializing in early-stage acceleration. As Chief Innovation Officer at ODDIFACT, he has led the rapid structuring and FDA submission of multiple biologic repositioning projects, securing five Orphan Drug Designations in under a year. This success is rooted in close, daily collaboration with experienced pharmacists and scientists, combining deep domain expertise with executional agility. Known for his ability to translate vision into action, Mehdi-Alexandre combines regulatory insight, product-market fit, and AI integration to build scalable health innovations. His strength lies in launching complex initiatives with speed, clarity, and cross-functional alignment turning early momentum into long-term value.